abstract |
This invention relates to novel α-[(phenylmethoxy)methyl]-pyridinealkanol derivatives useful in the treatment of diseases or disorders mediated by platelet-activating factor. This invention further relates to pharmaceutical compositions of such α-[(phenylmethoxy)methyl]pyridinealkanol derivatives. |